Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Arteriotomy Closure Devices Market by Type (Active Devices, Passive Devices): Global Opportunity Analysis and Industry Forecast, 2023-2032

A04137

Pages: NA

Charts: NA

Tables: NA

Arteriotomy is a general term used for an opening or cut of an artery wall during vascular surgical procedures. Arteriotomy closure devices are used to close the cut in arteries after the surgery.

Increase in incidences of vascular disorders and rise in risk factors (such as smoking, unhealthy diet, and sedentary lifestyle) that lead to vascular complications drive the market. In addition, rise in geriatric population also propel the market growth. However, risks associated with some of the devices restrain the market. Developments in arteriotomy closure devices will provide opportunities for the market growth.

The report segments the global arteriotomy closure devices market based on type and region. Based on type, it is divided into active devices (plugs, sutures, and clips) and passive devices (compression devices, sealants, and patches). By geography, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

Key players that operate in the market include Abbott Laboratories, Cardinal Health, Inc., Vasorum Ltd., and Cardival Medical, Inc.

Key Benefits

  • The study provides an in-depth analysis of the global market with current trends and future estimations to elucidate imminent investment pockets.
  • The report provides a quantitative analysis which is expected to enable stakeholders to capitalize on prevailing market opportunities.
  • Competitive intelligence highlights the business practices followed by leading players across various regions.
  • Comprehensive analysis of all geographic regions is provided that helps determine prevailing opportunities in these regions.
  • Key market players within the market are profiled in the report and their strategies thoroughly analyzed, which elucidates the competitive outlook of the global market.
  • Extensive analysis of the market has been conducted by closely following key product positioning and monitoring the top contenders within the market framework

 Key Market Segments

  • By Type
    • Active Devices
      • Plugs
      • Sutures
      • Clips
    • Passive Devices
      • Compression Devices
      • Patches
      • Sealants
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA

 
Key Market Players

  • Meril Life Sciences Pvt. Ltd
  • Merit Medical Systems, Inc.
  • Vasorum Ltd.
  • Cardinal Health, Inc.
  • Teleflex Incorporated
  • Abbott Laboratories
  • Morris Innovative, Inc.
  • Cardival Medical, Inc
  • Medtronic Plc
  • Terumo Corporation

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: ARTERIOTOMY CLOSURE DEVICES MARKET, BY TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Type

    • 4.2. Active Devices

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

      • 4.2.4. Plugs

        • 4.2.4.1. Market Size and Forecast

      • 4.2.4. Sutures

        • 4.2.4.1. Market Size and Forecast

      • 4.2.4. Clips

        • 4.2.4.1. Market Size and Forecast

    • 4.3. Passive Devices

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

      • 4.3.4. Compression Devices

        • 4.3.4.1. Market Size and Forecast

      • 4.3.4. Patches

        • 4.3.4.1. Market Size and Forecast

      • 4.3.4. Sealants

        • 4.3.4.1. Market Size and Forecast

  • CHAPTER 5: ARTERIOTOMY CLOSURE DEVICES MARKET, BY REGION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Region

    • 5.2. North America

      • 5.2.1. Key Market Trends and Opportunities

      • 5.2.2. Market Size and Forecast, By Type

      • 5.2.3. Market Size and Forecast, By Country

      • 5.2.4. U.S. Arteriotomy Closure Devices Market

        • 5.2.4.1. Market Size and Forecast, By Type

      • 5.2.5. Canada Arteriotomy Closure Devices Market

        • 5.2.5.1. Market Size and Forecast, By Type

      • 5.2.6. Mexico Arteriotomy Closure Devices Market

        • 5.2.6.1. Market Size and Forecast, By Type

    • 5.3. Europe

      • 5.3.1. Key Market Trends and Opportunities

      • 5.3.2. Market Size and Forecast, By Type

      • 5.3.3. Market Size and Forecast, By Country

      • 5.3.4. France Arteriotomy Closure Devices Market

        • 5.3.4.1. Market Size and Forecast, By Type

      • 5.3.5. Germany Arteriotomy Closure Devices Market

        • 5.3.5.1. Market Size and Forecast, By Type

      • 5.3.6. Italy Arteriotomy Closure Devices Market

        • 5.3.6.1. Market Size and Forecast, By Type

      • 5.3.7. Spain Arteriotomy Closure Devices Market

        • 5.3.7.1. Market Size and Forecast, By Type

      • 5.3.8. UK Arteriotomy Closure Devices Market

        • 5.3.8.1. Market Size and Forecast, By Type

      • 5.3.9. Russia Arteriotomy Closure Devices Market

        • 5.3.9.1. Market Size and Forecast, By Type

      • 5.3.10. Rest Of Europe Arteriotomy Closure Devices Market

        • 5.3.10.1. Market Size and Forecast, By Type

    • 5.4. Asia-Pacific

      • 5.4.1. Key Market Trends and Opportunities

      • 5.4.2. Market Size and Forecast, By Type

      • 5.4.3. Market Size and Forecast, By Country

      • 5.4.4. China Arteriotomy Closure Devices Market

        • 5.4.4.1. Market Size and Forecast, By Type

      • 5.4.5. Japan Arteriotomy Closure Devices Market

        • 5.4.5.1. Market Size and Forecast, By Type

      • 5.4.6. India Arteriotomy Closure Devices Market

        • 5.4.6.1. Market Size and Forecast, By Type

      • 5.4.7. South Korea Arteriotomy Closure Devices Market

        • 5.4.7.1. Market Size and Forecast, By Type

      • 5.4.8. Australia Arteriotomy Closure Devices Market

        • 5.4.8.1. Market Size and Forecast, By Type

      • 5.4.9. Thailand Arteriotomy Closure Devices Market

        • 5.4.9.1. Market Size and Forecast, By Type

      • 5.4.10. Malaysia Arteriotomy Closure Devices Market

        • 5.4.10.1. Market Size and Forecast, By Type

      • 5.4.11. Indonesia Arteriotomy Closure Devices Market

        • 5.4.11.1. Market Size and Forecast, By Type

      • 5.4.12. Rest of Asia Pacific Arteriotomy Closure Devices Market

        • 5.4.12.1. Market Size and Forecast, By Type

    • 5.5. LAMEA

      • 5.5.1. Key Market Trends and Opportunities

      • 5.5.2. Market Size and Forecast, By Type

      • 5.5.3. Market Size and Forecast, By Country

      • 5.5.4. Brazil Arteriotomy Closure Devices Market

        • 5.5.4.1. Market Size and Forecast, By Type

      • 5.5.5. South Africa Arteriotomy Closure Devices Market

        • 5.5.5.1. Market Size and Forecast, By Type

      • 5.5.6. Saudi Arabia Arteriotomy Closure Devices Market

        • 5.5.6.1. Market Size and Forecast, By Type

      • 5.5.7. UAE Arteriotomy Closure Devices Market

        • 5.5.7.1. Market Size and Forecast, By Type

      • 5.5.8. Argentina Arteriotomy Closure Devices Market

        • 5.5.8.1. Market Size and Forecast, By Type

      • 5.5.9. Rest of LAMEA Arteriotomy Closure Devices Market

        • 5.5.9.1. Market Size and Forecast, By Type

  • CHAPTER 6: COMPETITIVE LANDSCAPE

    • 6.1. Introduction

    • 6.2. Top Winning Strategies

    • 6.3. Product Mapping Of Top 10 Player

    • 6.4. Competitive Dashboard

    • 6.5. Competitive Heatmap

    • 6.6. Top Player Positioning, 2024

  • CHAPTER 7: COMPANY PROFILES

    • 7.1. Abbott Laboratories

      • 7.1.1. Company Overview

      • 7.1.2. Key Executives

      • 7.1.3. Company Snapshot

      • 7.1.4. Operating Business Segments

      • 7.1.5. Product Portfolio

      • 7.1.6. Business Performance

      • 7.1.7. Key Strategic Moves and Developments

    • 7.2. Cardinal Health, Inc.

      • 7.2.1. Company Overview

      • 7.2.2. Key Executives

      • 7.2.3. Company Snapshot

      • 7.2.4. Operating Business Segments

      • 7.2.5. Product Portfolio

      • 7.2.6. Business Performance

      • 7.2.7. Key Strategic Moves and Developments

    • 7.3. Vasorum Ltd.

      • 7.3.1. Company Overview

      • 7.3.2. Key Executives

      • 7.3.3. Company Snapshot

      • 7.3.4. Operating Business Segments

      • 7.3.5. Product Portfolio

      • 7.3.6. Business Performance

      • 7.3.7. Key Strategic Moves and Developments

    • 7.4. Cardival Medical, Inc

      • 7.4.1. Company Overview

      • 7.4.2. Key Executives

      • 7.4.3. Company Snapshot

      • 7.4.4. Operating Business Segments

      • 7.4.5. Product Portfolio

      • 7.4.6. Business Performance

      • 7.4.7. Key Strategic Moves and Developments

    • 7.5. Terumo Corporation

      • 7.5.1. Company Overview

      • 7.5.2. Key Executives

      • 7.5.3. Company Snapshot

      • 7.5.4. Operating Business Segments

      • 7.5.5. Product Portfolio

      • 7.5.6. Business Performance

      • 7.5.7. Key Strategic Moves and Developments

    • 7.6. Medtronic Plc

      • 7.6.1. Company Overview

      • 7.6.2. Key Executives

      • 7.6.3. Company Snapshot

      • 7.6.4. Operating Business Segments

      • 7.6.5. Product Portfolio

      • 7.6.6. Business Performance

      • 7.6.7. Key Strategic Moves and Developments

    • 7.7. Morris Innovative, Inc.

      • 7.7.1. Company Overview

      • 7.7.2. Key Executives

      • 7.7.3. Company Snapshot

      • 7.7.4. Operating Business Segments

      • 7.7.5. Product Portfolio

      • 7.7.6. Business Performance

      • 7.7.7. Key Strategic Moves and Developments

    • 7.8. Teleflex Incorporated

      • 7.8.1. Company Overview

      • 7.8.2. Key Executives

      • 7.8.3. Company Snapshot

      • 7.8.4. Operating Business Segments

      • 7.8.5. Product Portfolio

      • 7.8.6. Business Performance

      • 7.8.7. Key Strategic Moves and Developments

    • 7.9. Merit Medical Systems, Inc.

      • 7.9.1. Company Overview

      • 7.9.2. Key Executives

      • 7.9.3. Company Snapshot

      • 7.9.4. Operating Business Segments

      • 7.9.5. Product Portfolio

      • 7.9.6. Business Performance

      • 7.9.7. Key Strategic Moves and Developments

    • 7.10. Meril Life Sciences Pvt. Ltd

      • 7.10.1. Company Overview

      • 7.10.2. Key Executives

      • 7.10.3. Company Snapshot

      • 7.10.4. Operating Business Segments

      • 7.10.5. Product Portfolio

      • 7.10.6. Business Performance

      • 7.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET FOR ACTIVE DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET FOR PASSIVE DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. NORTH AMERICA ARTERIOTOMY CLOSURE DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. NORTH AMERICA ARTERIOTOMY CLOSURE DEVICES, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 7. U.S. ARTERIOTOMY CLOSURE DEVICES, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 8. CANADA ARTERIOTOMY CLOSURE DEVICES, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 9. MEXICO ARTERIOTOMY CLOSURE DEVICES, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 10. EUROPE ARTERIOTOMY CLOSURE DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. EUROPE ARTERIOTOMY CLOSURE DEVICES, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 12. FRANCE ARTERIOTOMY CLOSURE DEVICES, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 13. GERMANY ARTERIOTOMY CLOSURE DEVICES, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 14. ITALY ARTERIOTOMY CLOSURE DEVICES, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 15. SPAIN ARTERIOTOMY CLOSURE DEVICES, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 16. UK ARTERIOTOMY CLOSURE DEVICES, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 17. RUSSIA ARTERIOTOMY CLOSURE DEVICES, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 18. REST OF EUROPE ARTERIOTOMY CLOSURE DEVICES, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 19. ASIA-PACIFIC ARTERIOTOMY CLOSURE DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 20. ASIA-PACIFIC ARTERIOTOMY CLOSURE DEVICES, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 21. CHINA ARTERIOTOMY CLOSURE DEVICES, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 22. JAPAN ARTERIOTOMY CLOSURE DEVICES, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 23. INDIA ARTERIOTOMY CLOSURE DEVICES, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 24. SOUTH KOREA ARTERIOTOMY CLOSURE DEVICES, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 25. AUSTRALIA ARTERIOTOMY CLOSURE DEVICES, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 26. THAILAND ARTERIOTOMY CLOSURE DEVICES, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 27. MALAYSIA ARTERIOTOMY CLOSURE DEVICES, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 28. INDONESIA ARTERIOTOMY CLOSURE DEVICES, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 29. REST OF ASIA PACIFIC ARTERIOTOMY CLOSURE DEVICES, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 30. LAMEA ARTERIOTOMY CLOSURE DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 31. LAMEA ARTERIOTOMY CLOSURE DEVICES, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 32. BRAZIL ARTERIOTOMY CLOSURE DEVICES, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 33. SOUTH AFRICA ARTERIOTOMY CLOSURE DEVICES, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 34. SAUDI ARABIA ARTERIOTOMY CLOSURE DEVICES, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 35. UAE ARTERIOTOMY CLOSURE DEVICES, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 36. ARGENTINA ARTERIOTOMY CLOSURE DEVICES, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 37. REST OF LAMEA ARTERIOTOMY CLOSURE DEVICES, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 38. ABBOTT LABORATORIES: KEY EXECUTIVES
  • TABLE 39. ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • TABLE 40. ABBOTT LABORATORIES: OPERATING SEGMENTS
  • TABLE 41. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 42. ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 43. CARDINAL HEALTH, INC.: KEY EXECUTIVES
  • TABLE 44. CARDINAL HEALTH, INC.: COMPANY SNAPSHOT
  • TABLE 45. CARDINAL HEALTH, INC.: OPERATING SEGMENTS
  • TABLE 46. CARDINAL HEALTH, INC.: PRODUCT PORTFOLIO
  • TABLE 47. CARDINAL HEALTH, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 48. VASORUM LTD.: KEY EXECUTIVES
  • TABLE 49. VASORUM LTD.: COMPANY SNAPSHOT
  • TABLE 50. VASORUM LTD.: OPERATING SEGMENTS
  • TABLE 51. VASORUM LTD.: PRODUCT PORTFOLIO
  • TABLE 52. VASORUM LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 53. CARDIVAL MEDICAL, INC: KEY EXECUTIVES
  • TABLE 54. CARDIVAL MEDICAL, INC: COMPANY SNAPSHOT
  • TABLE 55. CARDIVAL MEDICAL, INC: OPERATING SEGMENTS
  • TABLE 56. CARDIVAL MEDICAL, INC: PRODUCT PORTFOLIO
  • TABLE 57. CARDIVAL MEDICAL, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 58. TERUMO CORPORATION: KEY EXECUTIVES
  • TABLE 59. TERUMO CORPORATION: COMPANY SNAPSHOT
  • TABLE 60. TERUMO CORPORATION: OPERATING SEGMENTS
  • TABLE 61. TERUMO CORPORATION: PRODUCT PORTFOLIO
  • TABLE 62. TERUMO CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 63. MEDTRONIC PLC: KEY EXECUTIVES
  • TABLE 64. MEDTRONIC PLC: COMPANY SNAPSHOT
  • TABLE 65. MEDTRONIC PLC: OPERATING SEGMENTS
  • TABLE 66. MEDTRONIC PLC: PRODUCT PORTFOLIO
  • TABLE 67. MEDTRONIC PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 68. MORRIS INNOVATIVE, INC.: KEY EXECUTIVES
  • TABLE 69. MORRIS INNOVATIVE, INC.: COMPANY SNAPSHOT
  • TABLE 70. MORRIS INNOVATIVE, INC.: OPERATING SEGMENTS
  • TABLE 71. MORRIS INNOVATIVE, INC.: PRODUCT PORTFOLIO
  • TABLE 72. MORRIS INNOVATIVE, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 73. TELEFLEX INCORPORATED: KEY EXECUTIVES
  • TABLE 74. TELEFLEX INCORPORATED: COMPANY SNAPSHOT
  • TABLE 75. TELEFLEX INCORPORATED: OPERATING SEGMENTS
  • TABLE 76. TELEFLEX INCORPORATED: PRODUCT PORTFOLIO
  • TABLE 77. TELEFLEX INCORPORATED: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 78. MERIT MEDICAL SYSTEMS, INC.: KEY EXECUTIVES
  • TABLE 79. MERIT MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT
  • TABLE 80. MERIT MEDICAL SYSTEMS, INC.: OPERATING SEGMENTS
  • TABLE 81. MERIT MEDICAL SYSTEMS, INC.: PRODUCT PORTFOLIO
  • TABLE 82. MERIT MEDICAL SYSTEMS, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 83. MERIL LIFE SCIENCES PVT. LTD: KEY EXECUTIVES
  • TABLE 84. MERIL LIFE SCIENCES PVT. LTD: COMPANY SNAPSHOT
  • TABLE 85. MERIL LIFE SCIENCES PVT. LTD: OPERATING SEGMENTS
  • TABLE 86. MERIL LIFE SCIENCES PVT. LTD: PRODUCT PORTFOLIO
  • TABLE 87. MERIL LIFE SCIENCES PVT. LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SEGMENTATION
  • FIGURE 2. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET
  • FIGURE 3. SEGMENTATION ARTERIOTOMY CLOSURE DEVICES MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN ARTERIOTOMY CLOSURE DEVICES MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALARTERIOTOMY CLOSURE DEVICES MARKET
  • FIGURE 11. ARTERIOTOMY CLOSURE DEVICES MARKET SEGMENTATION, BY BY TYPE
  • FIGURE 12. ARTERIOTOMY CLOSURE DEVICES MARKET FOR ACTIVE DEVICES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. ARTERIOTOMY CLOSURE DEVICES MARKET FOR PASSIVE DEVICES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 15. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 16. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 17. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 18. COMPETITIVE DASHBOARD
  • FIGURE 19. COMPETITIVE HEATMAP: ARTERIOTOMY CLOSURE DEVICES MARKET
  • FIGURE 20. TOP PLAYER POSITIONING, 2024
  • FIGURE 21. ABBOTT LABORATORIES: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 22. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 23. ABBOTT LABORATORIES: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 24. CARDINAL HEALTH, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 25. CARDINAL HEALTH, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 26. CARDINAL HEALTH, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 27. VASORUM LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 28. VASORUM LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 29. VASORUM LTD.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 30. CARDIVAL MEDICAL, INC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 31. CARDIVAL MEDICAL, INC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 32. CARDIVAL MEDICAL, INC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 33. TERUMO CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 34. TERUMO CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 35. TERUMO CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 36. MEDTRONIC PLC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 37. MEDTRONIC PLC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 38. MEDTRONIC PLC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 39. MORRIS INNOVATIVE, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 40. MORRIS INNOVATIVE, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 41. MORRIS INNOVATIVE, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 42. TELEFLEX INCORPORATED: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 43. TELEFLEX INCORPORATED: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 44. TELEFLEX INCORPORATED: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 45. MERIT MEDICAL SYSTEMS, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 46. MERIT MEDICAL SYSTEMS, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 47. MERIT MEDICAL SYSTEMS, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 48. MERIL LIFE SCIENCES PVT. LTD: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 49. MERIL LIFE SCIENCES PVT. LTD: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 50. MERIL LIFE SCIENCES PVT. LTD: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Arteriotomy Closure Devices Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved